STJ's slide presentation involving AF initiatives included discussion of STJ's initial magnetic guided rf ablation catheter designed for use on STXS' Niobe platform. STJ has indicated it expects the catheter will be available in Europe later this year.
One prominent analyst issued a STXS "Company Alert" and suggests that investors "stay tuned" for more strategic developments on STXS as this news directly involves both STJ and JNJ, the two largest players in the EP disposables business.
As a STXS shareholder, this morning's press release from the company was a pleasant follow on to last Friday's news. See the STXS board if interested, but be aware the paid basher there will require around 20 ignore files. rofl